Due to the crosstalk between the PI3K/AKT/mTOR and RAS/MAPK pathways, phosphorylation levels of AKT, S6RP, and mTOR have been previously used as biomarkers in research on RASopathies [16,78] (Figure 2). This evidence concerns the gene MTOR and RASopathy.